Adaptive Biotechnologies Market Cap

Adaptive Biotechnologies has a market cap or net worth of $2.16 billion as of April 28, 2026. Its market cap has increased by 83.25% in one year.

Market Cap

2.16B

Enterprise Value

2.13B

1-Year Change

83.25%

Ranking

#1997

Market Cap Chart

Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.16B, a decrease of -54.72%. That is a compound annual growth rate of -10.94%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	2.16B	-12.80%
Dec 31, 2025	2.48B	180.23%
Dec 31, 2024	884.74M	24.72%
Dec 29, 2023	709.39M	-35.07%
Dec 30, 2022	1.09B	-72.41%
Dec 31, 2021	3.96B	-51.03%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sarepta Therapeutics	2.21B
Ascentage Pharma Group International	2.16B
Mineralys Therapeutics	2.13B
Definium Therapeutics	2.12B
Tyra Biosciences	2.09B
Aurinia Pharmaceuticals	2.08B
Stoke Therapeutics	2.08B
Zymeworks	2.06B

Market Cap Rankings